XiRan Medical Completes Nearly RMB 100 Million Series A Funding Round

News on December 27: Hangzhou Xiran Medical Device Technology Co., Ltd. (referred to as "Rhino Health"), a developer of high-end ophthalmic surgical equipment, has completed nearly RMB 100 million in Series A financing. This round of financing was led by Legend Capital, with continued support from existing shareholders Taiyu Investment, StarVest Capital, Daotong Investment, and Daoyuan Capital.

Rhino Health, established in 2020, is a technology-based ophthalmic surgical equipment manufacturer and also an ophthalmic product company that provides one-stop training services for surgeons. Core products include phacoemulsification systems, vitrectomy surgery systems, ultrasonic vitrectomy, laser vitrectomy systems, and intraoperative OCT.